日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial

在韩国2型糖尿病患者中,二甲双胍治疗方案中加入伊格列净:一项3期试验的亚组分析

Min, Kyung Wan; Ku, Bon Jeong; Lee, Ji Hyun; Kim, Min Seon; Ahn, Kyu Jeung; Lee, Moon Kyu; Kokubo, Satoshi; Yoshida, Satoshi; Cho, Hyun Ji; Cha, Bong Soo

Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial

伊格列净治疗二甲双胍血糖控制不佳的亚洲2型糖尿病患者的疗效、安全性和耐受性:一项3期随机、安慰剂对照、双盲、多中心试验的结果

Lu, Chieh-Hsiang; Min, Kyung Wan; Chuang, Lee-Ming; Kokubo, Satoshi; Yoshida, Satoshi; Cha, Bong-Soo

Activation of p38 mitogen-activated protein kinase promotes peritoneal fibrosis by regulating fibrocytes

p38丝裂原活化蛋白激酶的激活通过调节纤维细胞促进腹膜纤维化

Kokubo, Satoshi; Sakai, Norihiko; Furuichi, Kengo; Toyama, Tadashi; Kitajima, Shinji; Okumura, Toshiya; Matsushima, Kouji; Kaneko, Shuichi; Wada, Takashi

Fas Ligand Has a Greater Impact than TNF-α on Apoptosis and Inflammation in Ischemic Acute Kidney Injury.

Fas 配体对缺血性急性肾损伤中的细胞凋亡和炎症的影响大于 TNF-α

Furuichi Kengo, Kokubo Satoshi, Hara Akinori, Imamura Ryu, Wang Qiang, Kitajima Shinji, Toyama Tadashi, Okumura Toshiya, Matsushima Kouji, Suda Takashi, Mukaida Naofumi, Kaneko Shuichi, Wada Takashi